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Research on microbe-host interactions focuses principally on pathogens, yet our immune system 
must deal with the huge number of beneficial commensal bacteria in our gut. It is becoming clear 
that the host immune system must reach a delicate balance between destroying dangerous bacte-
rial pathogens while preserving the beneficial gut microbiota.We can ignore the astronomical number 
of microorganisms that populate our gut, 
skin, and other mucosal surfaces, yet our 
immune system cannot. In the mamma-
lian gut, there is an increasing gradient 
from jejunum to ileum to rectum of resi-
dent microorganisms that peaks in the 
colon at a concentration of 1010 per gram 
of stool. This vast complex community 
comprises 1000 or more different bacte-
rial species and has a metabolic capac-
ity comparable to that of the liver (Frank 
and Pace, 2008). Most of the gut micro-
biota is composed of obligate anaerobic 
bacteria that cannot be grown in culture. 
The majority are harmless commensals 
that benefit from the nutrient-rich envi-
ronment offered by the host. Some are 
symbionts that also provide a benefit 
to the host, thereby establishing a con-
dition of mutualism. Here, we will use 
the term commensal in a broad sense, 
regardless of whether the bacteria are 
also symbionts.
Most of the gut microbiota belong to 
the Firmicutes (Gram-positive anaer-
obes) and Bacteroidetes (Gram-negative 
anaerobes), with far fewer belonging to 
the oxygen-adapted Proteobacteria and 
Actinobacteria. The resident gut micro-
biota can provide two major benefits to 
the host: release of nutrients from food 
and formation of a barrier against patho-
gens (Sansonetti, 2004). The gut micro-
biota exerts a right of “first occupancy” 
precluding other microorganisms, par-
ticularly pathogens, from invading the 
occupied niche. It also strengthens the 
gut epithelial barrier, both mechanically 
and immunologically. The nutritional 
input of the gut microbiota is indispensi-
ble for the host enabling the synthesis of 416 Cell 138, August 7, 2009 ©2009 Elseviercertain vitamins, hydrolysis of complex 
plant sugars, and production of short-
chain fatty acids for direct assimilation 
by the host.
Although colonization of the gut and 
other tissues by commensal bacteria 
is common to all metazoans, its extent 
increased during evolution particularly 
in vertebrates, due to the emergence of 
new organs that could be colonized (Ley 
et al., 2008). With this increase in colo-
nization, metazoans became dependent 
on an increasingly elaborate relationship 
with their gut flora. The coevolution of 
hosts and their commensal microbiota 
had a particularly strong impact on the 
immune system, which had to develop 
the ability to discriminate between the 
continuously resident microbiota, with 
which it actively maintains a homeostatic 
balance, and the invasive pathogens, 
to which it must respond. Here, we will 
explore the elusive barrier that separates 
these two types of host-microbial inter-
actions and the possible mechanisms 
and consequences for the failure to 
maintain this delicate balance.
Learning Tolerance
Tolerance of the host immune system 
toward gut commensals is mediated by 
three key players: the microbes them-
selves, the gut epithelium, and the 
immune cells that reside in lymphoid 
tissue in the lamina propria of the gut 
wall (Figure 1). Induction of immune tol-
erance and maintenance of the homeo-
static balance reflects a series of strate-
gies: avoidance of immune recognition 
by commensals, active suppression of 
the host response by commensals, and 
regulation of the immune response by  Inc.the host when recognition of commen-
sals does occur. If a group of commen-
sals is able to avoid immune recognition, 
active suppression of the host response 
may not be necessary. Likewise, if active 
suppression of the immune response is 
established by certain commensals, reg-
ulation of the immune response by the 
host may not be as critical.
To avoid immune recognition, com-
mensal microorganisms must fail to 
express key virulence factors. One issue 
that needs more study is the degree of 
diversity in pathogen-associated molec-
ular patterns (PAMPs) in commensals 
compared to pathogens. PAMPs, such 
as lipopolysaccharide (LPS) and pepti-
doglycans, are the structural elements 
of prokaryotes to which immune cells 
respond. For example, lipid A, the endo-
toxin moiety of LPS in Gram-negative 
bacteria, is pentacylated in the Bacte-
roidetes species that dominate the gut 
microbiota. This modification makes the 
lipid A of Bacteroidetes a poor agonist 
for Toll-like receptor 4 (TLR4), the recep-
tor expressed by immune cells that is 
activated by LPS (Coats et al., 2007). 
Conversely, the lipid A of commensal 
Proteobacteria is hexacylated, making 
it strongly endotoxic and more likely to 
elicit an immune response (Munford and 
Varley, 2006). The effect of Proteobacte-
ria lipid A as a potent agonist for TLR4 
is diluted out in the gut because of the 
predominance of Bacteroidetes species. 
However, during inflammation associ-
ated with inflammatory bowel disease or 
intestinal infection, there is a decrease 
in Bacteroidetes and Firmicutes species 
and an increase in Proteobacteria, which 
are more resistant to inflammatory medi-
Figure 1. The Interface between the Gut Epithelium and Its Resident Microbiota
The gut epithelium is on the frontline of interactions with the resident microbiota and is a major effector of immune tolerance. It induces tolerance by sensing 
the number of bacteria and their distance from the epithelial surface using a combination of receptors such as Toll-like receptors (TLRs) and NOD-like recep-
tors (NLRs) that sample pathogen-associated molecular patterns (PAMPs). The gut epithelium then integrates this information and strategically responds to 
bacterial pathogens with inflammatory signals or to harmless commensals with immune tolerance signals. Molecules such as thymic stromal lymphopoietin 
(TSLP), transforming growth factor-β (TGF-β), interleukin-10 (IL-10), and prostaglandin E2 (PGE2) are essential mediators released by intestinal epithelial cells 
that regulate the production of proinflammatory cytokines. In this way, macrophages and dendritic cells, which are resident in the gut lamina propria are main-
tained in an anergic noninflammatory state resulting in the predominance of T regulatory lymphocytes (Tregs). Dendritic cells can transcytose between epithelial 
cells, capturing lumenal bacteria or sensing PAMPs, and also may participate in the induction of immune tolerance. In response to the presence of commensal 
bacteria, the intestinal epithelium also produces mediators such as B cell activation factor (BAFF), proliferation-inducing ligand (APRIL), and SUN-like protein 
(SLP1). These factors stimulate the maturation and proliferation of B lymphocytes that have been primed by the commensal bacteria sampled through M cells 
in the lymphoid tissue of the intestinal tract and mesenteric lymph nodes. The resulting mature B cells (plasmocytes) express a repertoire of IgA antibodies 
against commensal antigens. The plasmocytes enter the circulation and home to the intestinal mucosa where they produce secretory dimeric IgA antibodies 
that move into the gut lumen via the poly Ig receptor expressed by epithelial tissue. IgA participates in the homeostatic process by removing commensals from 
the epithelial surface.ators (Lupp et al., 2007). This may result 
in an exacerbation of intestinal inflam-
mation. Thus, homeostasis is highly 
dependent on maintaining the balance 
between strictly anaerobic and aero-tol-
erant microbes and their relative expres-
sion of immunostimulatory PAMPs.
Not Just Ignorant Bystanders
Maintenance of immune homeostasis 
toward commensal microorganisms is 
not mediated exclusively by tolerance. 
Increasing evidence indicates that some 
commensal bacteria have the capac-
ity to actively suppress inflammation, 
particularly by targeting NF-κB, a key 
mediator of the inflammatory response. 
Some bacteria, such as nonpathogenic 
Salmonella, block the ubiquitination of IκBα catalyzed by the E3-SCF (βTrCP) 
ubiquitin ligase by neddylating cullin-1. 
This prevents degradation of IκBα, 
which keeps NF-κB in its inactive state 
and prevents transcription of NF-κB 
target genes including those encoding 
proinflammatory factors (Collier-Hyams 
et al., 2005). The bacterium Bacteroi-
des thetaiotaomicron targets the NF-κB 
subunit RelA, enhancing its export from 
the nucleus through a mechanism that is 
independent of the nuclear export recep-
tor Crm-1 but dependent on formation 
of a complex with PPARγ. This prevents 
transcription of the proinflammatory 
genes activated by NF-κB (Kelly et al., 
2003). Meanwhile, Lactobacillus casei 
induces transcriptional downregulation 
of Roc-1 (a subunit of E3-SCF) and of Cell 1several components of the proteasome 
complex, thereby protecting IκB from 
degradation (Tien et al., 2006). The chal-
lenge now is to identify the effectors of 
commensal microorganisms that medi-
ate the blockade of NF-κB activity. One 
clue comes from the study of a mouse 
model of colitis (Mazmanian et al., 2008). 
This study shows that the exopolysac-
charide of a gut bacterial species Bacte-
roides fragilis exerts a strong protec-
tive anti-inflammatory action against 
the induction of colitis by the pathogen 
Helicobacter hepaticus. It induces the 
protective effect by regulating produc-
tion of the cytokine interleukin-10 (IL-10) 
by immune cells of the gut. A systematic 
analysis of the characteristics of a lim-
ited number of gut microorganisms is 38, August 7, 2009 ©2009 Elsevier Inc. 417
needed to obtain a “commensal signa-
ture,” as has been done for gut patho-
gens. Particularly important questions to 
ask are, what are the effector molecules 
that enable commensals to occupy a 
niche and stay there, and what are the 
factors and mechanisms that alter the 
host immune response?
Gut Epithelium on the Frontline
The intestinal epithelium is a critical bar-
rier to invasion by pathogenic microbes. 
It is on the frontline of sensing microbes 
in the gut and participates in the innate 
immune response as a bona fide com-
ponent of the host immune system. The 
gut epithelium had to evolve under the 
double constraints of sensing microbes 
and adjusting the immune response 
to the perceived degree of threat. The 
result has been either constitutive “phys-
iological inflammation” that balances 
the constant presence of the resident 
gut microbiota or induced “pathologi-
cal inflammation,” the degree of which 
depends on the number and virulence 
of the invading pathogens. Physiological 
inflammation can be viewed as a basal 
sensing-responding loop that maintains a 
dynamic yet fragile homeostatic balance. 
The epithelium secretes factors such as 
mucins that establish a protective film 
of variable thickness and density, with 
the layer closest to the epithelial surface 
forming a dense lattice in which secreted 
antimicrobial molecules remain embed-
ded (Liévin-Le Moal and Servin, 2006). 
In general, commensal bacteria seem to 
grow at a respectable distance from this 
zone establishing a sort of “bacterial no 
man’s land.” This notion has been nicely 
confirmed with the demonstration that 
the densely packed inner mucin layer 
that is immediately adjacent to the epi-
thelial surface is devoid of bacteria in the 
mouse colon (Johansson et al., 2008). 
At the lumenal edge of the peripheral 
zone of the mucus layer, bacteria seem 
to establish complex communities often 
referred to as biofilms (Swidsinski et al., 
2005).
Distance does not mean ignorance, 
however. TLRs are expressed by gut epi-
thelial cells enabling them to detect bac-
teria, although receptors such as TLR4 
are present at low levels and may be 
devoid of coactivating molecules (Abreu 
et al., 2005). In addition, tolerance of the 418 Cell 138, August 7, 2009 ©2009 Elseviergut epithelium to major immune activa-
tors, such as bacterial LPS, is estab-
lished very early in life (Lotz et al., 2006). 
And recent evidence in the zebrafish 
indicates that alkaline phosphatase 
in the epithelial brush border actively 
detoxifies bacterial endotoxins in the gut 
lumen (Bates et al., 2007). From a coevo-
lutionary perspective, these observa-
tions suggest that LPS may be a major 
effector driving the mechanisms leading 
to immune tolerance to the gut micro-
biota.
The gut epithelium also actively moni-
tors the proximity and density of the res-
ident microbiota by sampling bacterial 
molecules via apical channels such as 
hPepT1 (Vavricka et al., 2004). Bacterial 
cell wall components, such as muramyl 
dipeptide, are transported into cells via 
these channels and may induce main-
tenance of a minimal level of “physio-
logical inflammation” by activating NOD 
(nucleotide-oligomerization domain) 
proteins (pattern recognition recep-
tors of the innate immune system) in the 
cytoplasm of gut epithelial and immune 
cells. In parallel, OCTN2, a cation trans-
porter on the apical surface of epithelial 
cells, is able to sample quorum-sensing 
molecules produced by bacterial com-
munities, leading to activation of stress 
signaling pathways mediated by MAPK, 
Akt kinase, and heat-shock proteins that 
maintain the integrity of the epithelial 
barrier (Fujiya et al., 2007). Similarly, the 
quorum-sensing regulator C12 selec-
tively impairs the activation of NF-κB 
in mammalian cells (Kravchenko et al., 
2008). TLRs also play a role in this com-
plex choreography: they are seques-
tered in the intestinal crypts that act as 
sanctuaries for stem cells and so must 
be protected. TLRs also mediate essen-
tial signals for proliferation of epithelial 
stem cells in these critical zones (Rakoff-
Nahoum et al., 2004). Thus, the intesti-
nal epithelium provides a highly suitable 
and adaptable frontline for microbiota to 
interact with the host and is much more 
than just a static defensive barrier.
Vertebrate hosts have had to develop 
both innate and adaptive tolerance toward 
commensal bacteria. Commensals are 
a source not only of PAMPs but also of 
foreign antigens that potentially can be 
recognized by the adaptive immune sys-
tem. Immune cells in the lamina propria  Inc.are actively maintained in a state of toler-
ance to the gut microbiota by epithelial 
cells. For example, intestinal epithelial 
cells produce factors such as thymic 
stromal lymphopoietin that ensure den-
dritic cells and macrophages in the gut 
do not induce an inflammatory response 
(Rimoldi et al., 2005). In addition, IKKβ 
produced by gut epithelial cells main-
tains this homeostatic balance by pro-
moting mucosal immunity and control-
ling intestinal inflammation (Zaph et al., 
2007). Similarly, epithelial IKKγ/NEMO is 
critical for maintaining epithelial integ-
rity and immune homeostasis (Nenci et 
al., 2007). The resident microbiota, by 
producing TLR-mediated signals, stimu-
lates expression of inhibitory factors that 
maintain tolerance. The local production 
of IgA antibodies directed against micro-
bial antigens is also part of the dynamic 
epithelial barrier that keeps the resident 
flora in check and allows downregulation 
of proinflammatory signals (Peterson et 
al., 2007). Finally, T regulatory lympho-
cytes (Tregs) in the gut subepithelium 
produce IL-10 and TGF-β, factors that 
are major contributors to inducing toler-
ance of the innate and adaptive immune 
systems to the resident gut microbiota 
(Izcue et al., 2006).
Failures of Tolerance
On the host side, any broken link in the 
chain that maintains physiological inflam-
mation can cause loss of the gut muco-
sa’s ability to keep the resident micro-
biota in check, leading to a switch from 
physiological to pathological inflamma-
tion. This may be a major cause of a type 
of inflammatory bowel disease called 
Crohn’s disease. In Crohn’s disease, 
mutations in the gene encoding NOD2, a 
key element of the homeostasis network, 
lead to decreased production of antimi-
crobial β-defensins by gut epithelial cells 
(Nuding et al., 2007). This enables com-
mensals to make intimate contact with 
the epithelial surface (Swidsinski et al., 
2002) resulting in a destructive mucosal 
inflammation.
Defects in the adaptive arm of immune 
tolerance to the resident microbiota also 
may lead to inflammation, and experi-
mental models confirm this (Hoffmann 
et al., 2003). Immunological analyses of 
gut tissue from Crohn’s disease patients 
indicate a strong bias in favor of T helper 
(Th) 1 and Th17 cells in the gut lamina 
propria, which are lymphocytes of the 
adaptive immune system that induce 
an inflammatory response (Arseneau et 
al., 2007). Genetic analyses of patients 
with inflammatory bowel disease will 
undoubtedly continue to provide key 
information regarding the essential mol-
ecules that regulate the homeostatic 
balance between the innate and adap-
tive immune systems of the gut and its 
resident microbiota.
Discriminating Commensals from 
Pathogens
Pathogens produce an arsenal of effec-
tors that enable them to achieve close 
proximity and colonization of the epithe-
lial surface followed by subversion and 
destabilization of the epithelial barrier. 
These effectors include adhesins, inva-
sins, proteases (mucinases), toxins, as 
well as PAMPs such as hexacylated lipid 
A. Some pathogens are able to dampen 
expression or destroy epithelial defenses 
such as mucus. Invasive microorganisms, 
such as Shigella, induce decreased pro-
duction of antimicrobial molecules such 
as β-defensins and cathelicidin, thereby 
achieving efficient colonization of epithe-
lial surfaces by escaping the bactericidal 
effects of these molecules (Spérandio 
et al., 2008). Together, these pathogenic 
properties result in a massive delivery of 
PAMPs and other signaling molecules 
to the epithelial and subepithelial sur-
veillance network of TLRs and Nod-like 
receptors (NLRs) expressed by gut epi-
thelial cells and immune cells (Figure 1).
The host immune system thus appears 
to have evolved under an antagonistic 
selective pressure enabling it to toler-
ate the beneficial gut microbiota on the 
one hand and to combat and eradicate 
pathogens on the other. The virulence of 
pathogens may be specifically sensed 
by the host resulting in an immune 
response, but what is sensed may be 
the specific and stereotypic effects of 
virulence on host tissues. An example of 
this includes disruption of the extracel-
lular matrix and basement membranes 
of epithelial cells by bacterial proteases. 
Another example is disruption of mem-
brane integrity by the pore-forming exo-
toxins of Gram-positive pathogens or by 
the type III secretion systems of Gram-
negative pathogens, which is sensed by the NALP3 inflammasome of mac-
rophages and other immune cells (Pétrilli 
et al., 2007). It is not simply tissue dam-
age per se, but rather the very specific 
alterations in tissue homeostasis associ-
ated with pathogen virulence that signal 
the immune system to mount a protec-
tive response.
Conclusion
Commensal bacteria are highly hetero-
geneous, and what counts is the combi-
nation of all of their individual properties. 
It is interesting to consider a “social” view 
of the ecology of this vast community. 
Genomic sequencing of individual spe-
cies, together with metagenomics that 
provides information on the genomes of 
most of the gut microbiota (the majority 
of which cannot be cultured), no doubt 
will confirm that some commensal micro-
organisms are potentially more harmful 
than others. This may be particularly true 
for Proteobacteria species including pro-
biotic strains like the Nissle 1917 strain 
that carries virulence genes (Grozdanov 
et al., 2004). These bacteria may be 
essential for the development of at least 
some signals that induce immune toler-
ance, such as those inducing tolerance 
to LPS, as long as their density is kept 
in check. Thus, the concept of “good” 
and “bad” commensals may not with-
stand a sociological view of the intestinal 
flora. Moreover, maintaining the balance 
among the different bacterial species 
that comprise the microbiota depends 
on the characteristics of the bacteria 
themselves and on certain environmen-
tal cues, particularly nutrition, which 
introduces another degree of complex-
ity. Inflammation of the gut epithelium 
also contributes to loss of homeostatic 
balance and expansion of potentially 
more aggressive microorganisms such 
as the Proteobacteria. This process may 
explain in part the chronic inflammation 
of inflammatory bowel disease. Like-
wise, innate immune signaling through 
the TLR/MyD88 pathway affects the 
composition of the intestinal microbiota, 
and this in turn affects the development 
of autoimmune diseases such as type 1 
diabetes (Wen et al., 2008). The notion of 
“good” and “bad” commensals thus may 
be a reflection of the balance between 
representative commensal species and 
the particular characteristics of the gut Cell 1milieu. We still have a lot to learn about 
how homeostasis is maintained between 
the gut and its microbiota. Deciphering 
the mechanisms of this homeostasis 
and its possible rupture will yield essen-
tial information about how development, 
tissue repair, and physiology can be 
affected by our microbial environment. 
At stake is our understanding and treat-
ment of major inflammatory diseases 
such as inflammatory bowel disease as 
well as colon cancer and other tumors. 
Other epithelial surfaces, such as those 
of the oral cavity and skin, will benefit 
from this global concept according to 
which only fighting ignorance guaran-
tees the virtue of tolerance.
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